NCT05133453 Pirfenidone Use in Asbestosis Patients: Efficacy and Prognosis Status NOT_YET_RECRUITING Phase NA
NCT04971746 Drug-drug Interaction Study with GLPG4716 and Nintedanib and Pirfenidone in Healthy Subjects Status COMPLETED Phase PHASE1
NCT04928586 Immunosuppressant Combined With Pirfenidone in CTD-ILD Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT04888715 To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04856111 Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia Status UNKNOWN Phase PHASE4
NCT04607928 Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19 Status UNKNOWN Phase PHASE2
NCT04461587 Examination of Pirfenidone (Esbriet®) Therapy in Coal Workers' Pneumoconiosis With Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT04282902 A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection Status UNKNOWN Phase PHASE3
NCT04258397 Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease Status UNKNOWN Phase PHASE2
NCT03981094 A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants Status COMPLETED Phase PHASE1
NCT03958071 A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking Status COMPLETED Phase N/A
NCT03902509 A Study About Safety and Efficacy of Pirfenidone to Treat Grade 2 or Grade3 Radiation-induced Lung Injury. Status COMPLETED Phase PHASE2
NCT03857854 Efficacy and Safety of Pirfenidone in Patient With Dermatomyositis Interstitial Lung Disease (Dm-ILD) Status UNKNOWN Phase PHASE3
NCT03856853 Efficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung Disease Status UNKNOWN Phase PHASE3
NCT03385668 Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies Status COMPLETED Phase PHASE2